Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy

doi:10.5501/wjv.v5.i1.14

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10277)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

686

WORD

447

HTML

3865

Figures (1-4)

224

Tables (1-2)

256

Sum=5478

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

527

Download

1492

Sum=2019

Publishing Process of This Article

Item

Count

Browse

1124

Download

1656

Sum=2780

Feb 12, 2016 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Virol. Feb 12, 2016; 5(1): 14-22
Published online Feb 12, 2016. doi: 10.5501/wjv.v5.i1.14

Full Size Figure Download Figure

Figure 4 Modeled prevalence (not exclusive¹) of hepatitis C virus infection by 6-year period, Libya, 2008-2055. ¹Estimates assume stable risk populations and HCV infection risks and do not adjust for treatment. HCV: Hepatitis C virus.

Citation: Daw MA, Shabash A, El-Bouzedi A, Dau AA, Habas M, Libyan Study Group of Hepatitis and HIV. Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy. World J Virol 2016; 5(1): 14-22
URL: https://www.wjgnet.com/2220-3249/full/v5/i1/14.htm
DOI: https://dx.doi.org/10.5501/wjv.v5.i1.14